News

AgroSpheres and BASF Announce Major Strategic Partnership

AgroSpheres, a biotechnology leader in sustainable crop protection and crop health, and BASF, a global leader in agricultural solutions, are excited to announce their strategic partnership on a category defining novel bioinsecticide. This collaboration marks a significant step forward in sustainable agriculture solutions aimed at enhancing crop protection.

The companies are working together to develop biological crop protection products leveraging AgroSpheres AgriCell-powered biomolecules. Both companies are encouraged by the levels of efficacy that have been demonstrated at low dose rates to control key agricultural lepidopteran pests. Both companies are committed to working together to develop innovative and sustainable crop protection products that will increase the choices available to farmers to manage pests and support optimal productivity.

Payam Pourtaheri, CoFounder and CEO of AgroSpheres, stated, “Our partnership with BASF exemplifies the synergy that can be achieved when innovative biotech meets extensive agricultural expertise. The results of our bioinsecticide development are extremely promising, and we are eager to continue our work together to bring effective solutions to farmers worldwide.”

Ameer Shakeel, CoFounder and CTO of AgroSpheres, added, “This collaboration is a testament to our team’s ability to develop novel biomolecules, amplify them with the AgriCell and forge strategic partnerships to reach farmers around the world. We are proud to partner with BASF and are excited about the potential impact of our partnership.”

Both companies are committed to furthering their research and development efforts, with plans to accelerate the development of this product line and launch a pipeline powered by the AgriCell.

Stephanie Jensen, Vice President, Crop System Rice and Portfolio Solutions Insecticides and Seed Treatment, BASF Agricultural Solutions, concluded, “We are incredibly encouraged by the results we’ve achieved thus far and by the potential impact for our customers from this innovative technology. Moving forward, our focus remains on delivering a bioinsecticide that adds genuine value for farmers, promoting higher yields and healthier crops.”

Stefan Tresch, Head of New Technologies & BioSolutions at BASF Agricultural Solutions, remarked, “BASF is dedicated to developing innovative solutions that provide added benefit to our agricultural customers, and we believe in the unique value represented by the AgriCell platform. AgroSpheres has showcased some of the most promising biomolecules we’ve encountered. Our collaboration with AgroSpheres is a testament to the power of partnerships in driving innovation.”

Both AgroSpheres and BASF are dedicated to fostering a sustainable agricultural ecosystem, and this partnership is a crucial step in that journey.

 

Learn more here.

Recent News

05/22/2026

BIO Statement on Veto of Prescription Drug Affordability Boards (PDAB) in VirginiaPatrick J. Plues, Senior Vice President of State Government Affairs & Affiliate Relations at the Biotechnology Innovation Organization (BIO) released the following statement on the veto of Prescription Drug Affordability Boards (PDAB) legislation in Virginia: “BIO applauds Governor Spanberger’s decision to veto SB 271 and HB 483 — legislation that would have established a Prescription Drug Affordability Board (PDAB) and imposed arbitrary price controls in Virginia. The Governor’s action recognized an important point: even well-intentioned healthcare policies must be carefully designed to avoid unintended consequences for patients, providers, employers, and Virginia’s innovation economy. “BIO is proud to represent biotechnology companies developing the next generation of life-changing medicines, including many in the Commonwealth. We believe policymakers play a critically important role in helping advance both patient access to treatments and the continued growth of the life sciences sector. “We look forward to working with the Governor’s Administration, the General Assembly, Virginia Bio and other stakeholders to advance practical, patient-centered policy solutions that improve affordability while preserving access to care and the innovation ecosystem patients depend on.”

Patrick J. Plues, Senior Vice President of State Government Affairs & Affiliate Relations at the Biotechnology Innovation Organization (BIO) released the following statement on the veto of Prescription Drug Affordability Boards (PDAB) legislation in Virginia: “BIO applauds Governor Spanberger’s decision to veto SB 271 and HB 483 — legislation that would have established a Prescription

05/21/2026

Virginia Bio Applauds Governor Spanberger’s Veto of SB 271 and HB 483

The Virginia Biotechnology Association (Virginia Bio) today expressed strong support for Governor Abigail Spanberger’s decision to veto Senate Bill 271 and House Bill 483, legislation that would have established a Prescription Drug Affordability Advisory Panel (PDAAP) in the Commonwealth. Virginia Bio and the Virginia Chamber of Commerce sent a joint letter to Governor Spanberger commending

05/21/2026

New Global Clinical Society to Bring Focused Ultrasound Into Mainstream Medicine

The Focused Ultrasound Foundation today announced the launch of the International Focused Ultrasound Society (IFUS), a new organization dedicated to advancing clinical practice and accelerating adoption of focused ultrasound – a revolutionary, noninvasive therapeutic technology. Established as a program of the Focused Ultrasound Foundation, IFUS aggregates and expands the Foundation’s activities related to clinical implementation